This is a proposal to study cortical-subcortical neurochemical circuitry in postmortem brain in schizophrenia. Dysregulation of dopaminergic neurotransmission has been frequently implicated in the pathogenesis and/or symptomatology of schizophrenia, since all antipsychotic medications affect the dopamine system in some fashion. The original """"""""dopamine hypothesis of schizophrenia"""""""" posited an increase in dopaminergic activity in the brain in this illness, but more recent evidence has led to a reconceptualization of this view. Specifically, the current view is that there is diminished dopaminergic activity in the cortex, which in turn leads to increased dopaminergic activity in the striatum. This interaction has been postulated to be transmitted via glutamatergic corticostriatal projections. Subsequent refinement suggests that corticostriatal glutamatergic and mesostriatal dopaminergic efferents converge in the striatum, and the dynamic balance between these two systems may be of importance in schizophrenia. Specifically, it has been suggested that schizophrenia may be associated with diminished glutamatergic or increased dopaminergic tone in the striatum, as part of a larger limbic circuit. Surprisingly, relatively little work has been done to date to examine these modified versions of the original dopamine hypothesis of schizophrenia. In our proposed work, we will employ the examination of messenger RNAs encoding dopamine and glutamate receptors in sectioned postmortem brain tissue to address the anatomically specific expression of these receptor genes, using a well-characterized set of tissue. These studies will allow the examination of these recent hypotheses of the involvement of the dopaminergic and glutamatergic regulation of cortical- subcortical circuits in schizophrenia, namely that (1): the brain dopamine systems are differentially regulated in schizophrenia, manifesting increased tone in the striatum but diminished activity in the limbic cortex; and (2) schizophrenia is associated with dysregulation of a feedback circuit consisting of corticostriatal glutamatergic and mesostriatal dopaminergic systems that mutually determine the activity of a striatothalamocortical information-processing network. This work represents the beginning of a comprehensive examination in human brain of these hypotheses of the neurochemistry and neuroanatomy underlying schizophrenia. These studies will provide a greater understanding of the circuitry underlying this illness, and how and where it may be disrupted.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH053327-03
Application #
2445552
Study Section
Neuropharmacology and Neurochemistry Review Committee (NPNC)
Project Start
1995-07-01
Project End
2000-06-30
Budget Start
1997-07-01
Budget End
1998-06-30
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Psychiatry
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Kim, Pitna; Scott, Madeline R; Meador-Woodruff, James H (2018) Abnormal expression of ER quality control and ER associated degradation proteins in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res :
Mueller, Toni M; Yates, Stefani D; Haroutunian, Vahram et al. (2017) Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia. Schizophr Res 182:66-73
McGuire, Jennifer L; Depasquale, Erica A; Funk, Adam J et al. (2017) Abnormalities of signal transduction networks in chronic schizophrenia. NPJ Schizophr 3:30
Pinner, Anita L; Tucholski, Janusz; Haroutunian, Vahram et al. (2016) Decreased protein S-palmitoylation in dorsolateral prefrontal cortex in schizophrenia. Schizophr Res 177:78-87
Bhambhvani, Hriday P; Simmons, Micah; Haroutunian, Vahram et al. (2016) Decreased expression of cortactin in the schizophrenia brain. Neuroreport 27:145-50
Scott, Madeline R; Rubio, Maria D; Haroutunian, Vahram et al. (2016) Protein Expression of Proteasome Subunits in Elderly Patients with Schizophrenia. Neuropsychopharmacology 41:896-905
McCullumsmith, R E; O'Donovan, S M; Drummond, J B et al. (2016) Cell-specific abnormalities of glutamate transporters in schizophrenia: sick astrocytes and compensating relay neurons? Mol Psychiatry 21:823-30
Mueller, T M; Remedies, C E; Haroutunian, V et al. (2015) Abnormal subcellular localization of GABAA receptor subunits in schizophrenia brain. Transl Psychiatry 5:e612
McCullumsmith, Robert E; Hammond, John H; Shan, Dan et al. (2015) Postmortem brain: an underutilized substrate for studying severe mental illness. Neuropsychopharmacology 40:1307
Kippe, Jordyn M; Mueller, Toni M; Haroutunian, Vahram et al. (2015) Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia. Schizophr Res 166:219-24

Showing the most recent 10 out of 85 publications